Clinical Scorecard: Cost-Effectiveness Analysis of a Digital Symptom Checker for Endometriosis Utilizing a Markov Decision Process Model
At a Glance
Category
Detail
Condition
Endometriosis
Key Mechanisms
Digital symptom checker facilitates earlier symptom recognition and prompts timely clinical engagement, reducing diagnostic delay and associated costs
Target Population
Women of reproductive age at risk for or experiencing symptoms of endometriosis
Care Setting
Primary care and digital health platforms
Key Highlights
Digital symptom checker reduced diagnostic delay by 4.36 years compared to standard care
Generated 0.049 incremental quality-adjusted life years (QALYs) per person over 40 years
Saved $5196.22 in costs per patient and yielded an incremental net monetary benefit of $10,089 at $100,000/QALY threshold
Guideline-Based Recommendations
Diagnosis
Utilize digital symptom checkers to support early identification of endometriosis symptoms
Incorporate symptom checker outputs to guide timely clinical evaluation and diagnostic pathways
Management
Integrate digital symptom checkers within female health platforms to facilitate patient self-assessment
Encourage compliance with symptom checker recommendations to maximize diagnostic and cost-effectiveness benefits
Monitoring & Follow-up
Monitor patient engagement and compliance with digital symptom checker recommendations
Evaluate diagnostic delays and healthcare utilization patterns to assess ongoing impact
Risks
Consider variability in symptom checker sensitivity and specificity; optimal cost-effectiveness observed with sensitivity and specificity ≥0.7
Address potential disruptions to patient-physician relationship through appropriate clinical integration
Patient & Prescribing Data
Women of reproductive age using the Flo digital symptom checker embedded in a female health app
Early symptom self-assessment via digital SC leads to earlier diagnosis, improved quality-adjusted life years, and substantial cost savings over long-term horizon
Clinical Best Practices
Implement digital symptom checkers as adjunct tools to standard care for earlier symptom recognition in endometriosis
Ensure symptom checkers have validated sensitivity and specificity ≥0.7 to maintain cost-effectiveness
Promote patient compliance with symptom checker recommendations, aiming for compliance rates above 45%
Adopt a long-term perspective (≥10 years) when evaluating the benefits of digital symptom checkers
Use symptom checkers to reduce healthcare system burden by streamlining patient triage and diagnostic pathways
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
